ArticleFrontiers in pediatrics2026
Neurodevelopmental regression Due to PLA2G6-associated neurodegeneration despite normal brain MRI: a case report.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Infantile neuroaxonal dystrophy is a rare autosomal recessive neurodegenerative disorder within the spectrum of PLA2G6-associated neurodegeneration. It is typically characterized by early psychomotor regression, progressive motor impairment, bulbar dysfunction, and characteristic neuroimaging abnormalities, including cerebellar atrophy and, in some cases, brain iron accumulation. Case report: We report the case of a 4-year-11-month-old girl with progressive neurodevelopmental regression beginning at approximately 18 months of age. The patient presented with loss of previously acquired motor abilities, absence of verbal language, marked hypotonia, preserved deep tendon reflexes, and progressive feeding difficulties. Laboratory evaluation was largely unremarkable, except for persistent isolated elevation of aspartate aminotransferase (AST). Brain MRI showed no overt structural or signal abnormalities despite advanced neurological impairment. Electroencephalography (EEG) did not reveal epileptiform activity. Given the progressive course and suspicion of an underlying neurodegenerative disorder, whole-exome sequencing was performed and identified a homozygous PLA2G6 variant, supporting the diagnosis of PLA2G6-associated neurodegeneration. During follow-up, the patient developed dysphagia and grade II gastroesophageal reflux, requiring gastrostomy placement and Nissen fundoplication. Conclusion: This case highlights the importance of early molecular diagnosis in pediatric regression syndromes and emphasizes that normal neuroimaging does not exclude PLA2G6-associated neurodegeneration, particularly in atypical presentations. Early recognition enables timely multidisciplinary management, prognostic assessment, and appropriate genetic counseling for the family.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.